Ocular Surface Disease

Latest News

EyeCool Therapeutics appoints Vance Thompson, MD, to board of directors
EyeCool Therapeutics appoints Vance Thompson, MD, to board of directors

September 3rd 2025

In addition to Thompson joining the board of directors, EyeCool also announced the members joining its newly formed medical advisory board (MAB).

What the eyes reveal: Cardiovascular clues in women—hidden in plain sight
What the eyes reveal: Cardiovascular clues in women—hidden in plain sight

August 13th 2025

Targeted therapies improve care for Demodex blepharitis and OSD
Targeted therapies improve care for Demodex blepharitis and OSD

June 19th 2025

Video Interviews
Podcasts
Latest CME Events & Activities

More News

© 2025 MJH Life Sciences

All rights reserved.